Projects per year
Personal profile
Personal profile
Dr. Kai Sun received her Bachelor of Science in Medicine and Master of Science in Medicine from Medical College of Qingdao University. She completed her Internal Medicine Residency at Houston Methodist Hospital. Dr. Sun then completed Hematology and Oncology Fellowship at Houston Methodist Hospital and served as the Chief Fellow.
Research interests
Dr Sun has a special interest in treating breast cancer. Her research interests include participation in clinical trials and research in obesity associated breast cancer.
External positions
Assistant Professor of Medicine, Weill Cornell Medicine
Apr 1 2023 → …
Research Area Keywords
- Cancer
- Clinical Care
- Clinical Translation & Trials
Fingerprint
Dive into the research topics where Kai Sun is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
IMPACT ON SURVIVAL OF FAITH-BASED SPIRITUAL CARE OR PSYCHOTHERAPY COMBINED WITH PALLIATIVE CARE VERSUS PALLIATIVE CARE ALONE IN PATIENTS WITH NON-CURATIVE MALIGNANCIES
Mai, H. P. (PI), Abanonu, C. (Key Personnel), Abdelrahim, M. (Key Personnel), Ganguly, S. (Key Personnel), Guan, J. (Key Personnel), Heyne, K. (Key Personnel), Mathur, S. (Key Personnel), Niravath, P. A. (Key Personnel), Pingali, S. R. (Key Personnel), Puri, A. (Key Personnel), Shah, S. (Key Personnel), Singh, M. (Key Personnel), Sun, K. (Key Personnel), Venta, L. A. (Key Personnel) & Zhang, J. (Key Personnel)
6/19/24 → …
Project: Clinical Trial
-
Fulvestrant Plus Abemaciclib With or Without Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
Niravath, P. A. (PI), Abanonu, C. (Key Personnel), Guan, J. (Key Personnel), Heyne, K. (Key Personnel), Mai, H. P. (Key Personnel), Mathur, S. (Key Personnel), Puri, A. (Key Personnel) & Sun, K. (Key Personnel)
7/15/21 → …
Project: Clinical Trial
-
Multicenter Phase I/Ib Trial of Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
Niravath, P. A. (PI), Abanonu, C. (Key Personnel), Guan, J. (Key Personnel), Puri, A. (Key Personnel) & Sun, K. (Key Personnel)
2/9/21 → …
Project: Clinical Trial
-
Metastatic Stem Cells-ROLE OF CANCER STEM CELLS IN BREAST CANCER RECURRENCE AND METASTASIS
Sun, K. (PI), Niravath, P. A. (Key Personnel) & Singh, M. (Key Personnel)
3/20/14 → …
Project: Clinical Trial
-
HER2-positive breast cancer in patients with BRCA1/2 pathogenic variants: Case series and literature review
Munnangi, P., Niravath, P. A., Chang, J. C. & Sun, K., Mar 2025, In: Current Problems in Cancer: Case Reports. 17, 100335.Research output: Contribution to journal › Article › peer-review
-
Utilization and Outcomes of the 21‐Gene Recurrence Score in pN2 Breast Cancer Patients
Haque, W., Verma, V., Mangalampalli, N., Schwartz, M. R., Butler, E. B., Sun, K., Jain, D., Arentz, C., Ramakrishnan, A. & Teh, B. S., Mar 2025, In: Anticancer Research. 45, 3, p. 1055-1061 7 p.Research output: Contribution to journal › Article › peer-review
-
5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer
Shao, J., Xu, Y., Olsen, R. J., Kasparian, S., Sun, K., Mathur, S., Zhang, J., He, C., Chen, S. H., Bernicker, E. H. & Li, Z., Apr 2024, In: Cells. 13, 8, 715.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Neighborhood Walkability Is Associated With Lower Burden of Cardiovascular Risk Factors Among Cancer Patients
Nwana, N., Makram, O. M., Nicolas, J. C., Pan, A., Gullapelli, R., Parekh, T., Javed, Z., Titus, A., Al-Kindi, S., Guan, J., Sun, K., Jones, S. L., Maddock, J. E., Chang, J. & Nasir, K., Jun 2024, In: JACC: CardioOncology. 6, 3, p. 421-435 15 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer
O’Neill, C. E., Sun, K., Sundararaman, S., Chang, J. C. & Glynn, S. A., 2024, In: Frontiers in Physiology. 15, 1358850.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations